Navigation Links
NVHR Applauds Congressional Action to End Federal Ban on Funding Syringe Exchange
Date:12/14/2009

Legislation Critical to Stemming Tide of Tens of Thousands of New Chronic Hepatitis Infections Annually

WASHINGTON, Dec. 14 /PRNewswire-USNewswire/ -- Legislation approved by Congress providing for federal funding of syringe exchange will be crucial in helping to reduce tens of thousands of new viral hepatitis infections occurring each year in the United States, the National Viral Hepatitis Roundtable (NVHR) said today. The provision was included in the FY 2010 Consolidated Appropriations bill approved by the House and Senate this weekend. President Obama is expected to sign the measure shortly.

The NVHR is a coalition of more than 150 public, private, and voluntary organizations dedicated to reducing the incidence of infection, morbidity, and mortality from viral hepatitis in the US through strategic planning, leadership, coordination, advocacy, and research. www.nvhr.org

"NVHR is pleased that Congress has acted on this sensible legislation that will reduce new viral hepatitis infections and ultimately save lives," said NVHR Chair Lorren Sandt. "Syringe exchange is a crucial tool in a comprehensive arsenal of counseling and medical referral programs designed to reduce drug use and infection. NVHR wishes to thank Representative Jose Serrano, Chairman David Obey, and thousands of activists for their tireless efforts in helping to address this critical public health issue."

An estimated 5.4 million Americans are infected with chronic viral hepatitis B and C and the majority are unaware they are infected. Injection drug use with shared syringes or equipment is the leading cause of hepatitis C, and 70 percent of people who inject drugs are infected. If left untreated, hepatitis B and C can cause serious liver disease, including cirrhosis, liver cancer, and liver failure. Needle exchange programs are an essential strategy to prevent the spread of hepatitis B and C infection, and provide vital counseling, testing, education, hepatitis A and B vaccine, and referral to medical care. According to the respected research firm Milliman, the cost of chronic hepatitis C virus infection alone could reach $85 billion annually by 2024, with Medicare and Medicaid absorbing a disproportionate share of those costs.

In early January 2010, the Institute of Medicine (IoM) is expected to release a report on viral hepatitis in the United States that outlines strategies for reducing the incidence of viral hepatitis infection and addressing medical complications in those individuals with chronic infections.

SOURCE National Viral Hepatitis Roundtable


'/>"/>
SOURCE National Viral Hepatitis Roundtable
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. SNM applauds FDAs issuing of new drug manufacturing requirements
2. Save Flexible Spending Plans Applauds Amendment to Protect Flexible Spending Accounts
3. Health Care Without Harm Applauds EPA Finding Climate Change is Danger to Public Health
4. Alzheimer's Foundation of America Applauds Inclusion of Cognitive Impairment Detection in Healthcare Reform
5. Wounded Warrior Project (WWP) Applauds the Senate for Passing Crucial Family Caregiver Legislation
6. Pelosi Applauds Provisions in Health Bill to Improve Access to Care, Medications for People Living With HIV/AIDS
7. American Academy of Physician Assistants Applauds U.S. House of Representatives for Passing Health Care Reform Bill
8. APHA Applauds Prevention and Wellness Provisions in House Health Reform Bill
9. National Alliance for Hispanic Health President and CEO Applauds House Action, Calls on Senate to Pass Health Reform in 2009
10. NAMI Applauds Initial Review of The Affordable Health Care of America Act and Health Care Reform
11. National Alliance for Hispanic Health Applauds Confirmation of Dr. Regina Benjamin as the 18th Surgeon General of the United States
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2016)... ... May 05, 2016 , ... TransWipe Volume 3 is a ... Drag and drop a TransWipe preset between two video clips to instantly add a ... to colored panels with customizable color and orientation options. TransWipe Volume 3 is a ...
(Date:5/5/2016)... ... May 05, 2016 , ... Qrono Inc. , ... a development collaboration with the Australian critical medicine company, Phebra Pty Ltd. ... , LAI medicines can offer improved therapeutic benefits over oral formulations, including better ...
(Date:5/5/2016)... , ... May 05, 2016 , ... Einstein Medical ... Twitter feed to cover the latest news and commentary at the 2016 ASCRS/ASOA Symposium ... meeting of the American Society of Cataract and Refractive Surgery and the American Society ...
(Date:5/5/2016)... , ... May 05, 2016 , ... This weekend, from Friday, May 6 - Sunday, ... steep California terrain at the first Team Semper Fi Mountain Bike Camp, hosted in conjunction ... be mountain bike legends Mark Weir and Jason Moeschler, who’ll share pro tips with the ...
(Date:5/5/2016)... ... May 05, 2016 , ... ... the Wharton Seminars for Business Journalists , led by the Wharton ... business and economic issues.  This one-day program at the Wharton School’s San ...
Breaking Medicine News(10 mins):
(Date:5/5/2016)... Research and Markets has announced the addition ... EU Markets"  report to their offering.  ,     (Logo: http://photos.prnewswire.com/prnh/20160330/349511LOGO ... the current Positron Emission Tomography (PET) scanner and cyclotron install ... includes France , Germany ... and the United Kingdom . Along ...
(Date:5/4/2016)... Holdings (NYSE: CODI ) ("CODI," "we," "our" ... businesses, announced today its consolidated operating results for the ... Quarter 2016 Highlights , Generated Cash Flow Available ... $13.6 million for the first quarter of 2016; ... first quarter of 2016; , Paid a first ...
(Date:5/4/2016)... JERUSALEM , May 4, 2016 ... University of Jerusalem announced today that it had ... BioTheryX, Inc. , developer of novel protein degradation ... the development and commercialization of drug candidates representing first-in-class ... the license were not disclosed. The novel ...
Breaking Medicine Technology: